Duloxetine Capsule, Delayed Release
Product Images NDC 71610-403
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71610-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Figure01 (Duloxetine Fig01)
The text describes a graph showing the proportion of patients who experienced a relapse over time in a study comparing a placebo with a drug called duloxetine. The x-axis measures the duration of time (in days) from randomization to relapse, while the y-axis measures the proportion of patients who relapsed. The study had 84 patients in the placebo group and 64 patients in the duloxetine group.*
Figure2 (Duloxetine Fig02)
Figure03 (Duloxetine Fig03)
Figure04 (Duloxetine Fig04)
Figure07 (Duloxetine Fig07)
Figure08 (Duloxetine Fig08)
The text appears to be a graph showing the percentage improvement in pain from baseline for patients taking Placebo and Duloxetine 60 mg once daily. The X-axis shows the percentage improvement while the Y-axis shows the number of patients. The graph shows that Duloxetine 60 mg was more effective in reducing pain compared to Placebo.*
Figure09 (Duloxetine Fig09)
Duloxetine-structure (Duloxetine Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.